1-17 of 17
Peter Dreger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study

Evgenii Shumilov, Rebecca Wurm-Kuczera, Andrea Kerkhoff, Meng Wang, Thomas Melchardt, Udo Holtick, Ulrike Bacher, Philipp B. Staber, Paolo Mazzeo, Corinna Leng, David Böckle, Alexander Sebastian Hölscher, Joseph Kauer, Natalia Rotter, Vladan Vucinic, Jakob D. Rudzki, David Nachbaur, Veit L. Bücklein, Ulf Schnetzke, Isabelle Krämer, Kai Wille, Alexander Hasse, Bastian von Tresckow, Mathias Hänel, Christian Koenecke, Giuliano Filippini Velazquez, Andreas Viardot, Christoph Schmid, Lorenz Thurner, Dominik Wolf, Marion Subklewe, Martin Dreyling, Peter Dreger, Sascha Dietrich, Ulrich Keller, Ulrich Jaeger, Richard Greil, Thomas Pabst, Georg Lenz, Björn Chapuy
Journal: Blood Advances
Blood Adv bloodadvances.2024014903.
https://doi.org/10.1182/bloodadvances.2024014903
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany

Aysenur Arslan, Svenja Labuhn, Elisa Sala, Mark Ringhoffer, Johannes Schetelig, Thomas Schröder, Gesine Bug, Georg-Nikolaus Franke, Matthias Stelljes, Peter Dreger, Robert Zeiser, Daniel Teschner, Wolfgang Bethge, Matthias Eder, Matthias Edinger, Elisa Maria Amann, Christine Neuchel, Amelie Schmid-Möglich, Sandra Schmeller, Jan Beyersmann, Hubert Schrezenmeier, Joannis Mytilineos, Nicolaus Kröger, Daniel Fürst
Journal: Blood Advances
Blood Adv (2024) 8 (23): 6104–6113.
https://doi.org/10.1182/bloodadvances.2024013719
Published: 2024
Includes: Supplemental data
Journal Articles

Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party study

Clinical Trials & Observations
Simon Renders, Maud Ngoya, Herve Finel, Marie-Thérèse Rubio, William Townsend, Roland Schroers, Urban Novak, Nicolaas Schaap, Mahmoud Aljurf, Grzegorz Helbig, Matthew Collin, Guido Kobbe, Anne Huynh, José Antonio Pérez-Simón, Adrian Bloor, Hervé Ghesquieres, Anna Sureda, Norbert Schmitz, Bertram Glass, Peter Dreger
Journal: Blood Advances
Blood Adv (2024) 8 (21): 5571–5578.
https://doi.org/10.1182/bloodadvances.2024013152
Published: 2024
Includes: Supplemental data
Journal Articles

Venetoclax-based salvage therapy as bridge-to-transplant is feasible and effective in patients with relapsed/refractory AML

Julia Marie Unglaub, Richard F. Schlenk, Jan M Middeke, Stefan W Krause, Sabrina Kraus, Hermann Einsele, Michael Kramer, Sven Zukunft, Joseph Kauer, Simon Renders, Elena Katelari, Christoph Schliemann, Caroline Pabst, Thomas Luft, Peter Dreger, Christoph Röllig, Martin Bornhäuser, Carsten Müller-Tidow, Tim Sauer
Journal: Blood Advances
Blood Adv bloodadvances.2024013086.
https://doi.org/10.1182/bloodadvances.2024013086
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study

Maria-Luisa Schubert, Wolfgang A. Bethge, Francis A. Ayuk, Malte von Bonin, Vladan Vucinic, Eva Marie Wagner-Drouet, Marion Subklewe, Claudia D. Baldus, Bertram Glass, Reinhard Marks, Dimitrios Mougiakakos, Roland Schroers, Matthias Stelljes, Max S. Topp, Gerald Wulf, Nicolaus Kröger, Peter Dreger
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6191–6195.
https://doi.org/10.1182/bloodadvances.2023011203
Published: 2023
Includes: Supplemental data
Journal Articles

Comparing the value of mono- vs coculture for high-throughput compound screening in hematological malignancies

Sophie A. Herbst, Vladislav Kim, Tobias Roider, Eva C. Schitter, Peter-Martin Bruch, Nora Liebers, Carolin Kolb, Mareike Knoll, Junyan Lu, Peter Dreger, Carsten Müller-Tidow, Thorsten Zenz, Wolfgang Huber, Sascha Dietrich
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5925–5936.
https://doi.org/10.1182/bloodadvances.2022009652
Published: 2023
Includes: Supplemental data
Journal Articles

EASIX-1year and late mortality after allogeneic stem cell transplantation

Clinical Trials & Observations
Lambros Kordelas, Tobias Terzer, Ted Gooley, Chris Davis, Brenda M. Sandmaier, Mohamed Sorror, Olaf Penack, Nigel D. E. Schaeper, Igor W. Blau, Dietrich Beelen, Aleksandar Radujkovic, Peter Dreger, Thomas Luft
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5374–5381.
https://doi.org/10.1182/bloodadvances.2022008617
Published: 2023
Includes: Supplemental data
Journal Articles

Real-world results of CAR T-cell therapy for large B-cell lymphoma with CNS involvement: a GLA/DRST study

Clinical Trials & Observations
Francis Ayuk, Nico Gagelmann, Bastian von Tresckow, Gerald Wulf, Kai Rejeski, Matthias Stelljes, Olaf Penack, Claudia D. Baldus, Nicolaus Kröger, Wolfgang Bethge, Peter Dreger
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5316–5319.
https://doi.org/10.1182/bloodadvances.2023010336
Published: 2023
Includes: Supplemental data
Journal Articles

Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy: a GLA/DRST study

Clinical Trials & Observations
Nico Gagelmann, Gerald Georg Wulf, Johannes Duell, Bertram Glass, Pearl van Heteren, Bastian von Tresckow, Monika Fischer, Olaf Penack, Francis Ayuk, Herrmann Einsele, Udo Holtick, Julia Thomson, Peter Dreger, Nicolaus Kröger
Journal: Blood Advances
Blood Adv (2023) 7 (4): 555–559.
https://doi.org/10.1182/bloodadvances.2022008042
Published: 2023
Includes: Supplemental data
Journal Articles

Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics

Clinical Trials & Observations
Mehdi Hamadani, Maud Ngoya, Anna Sureda, Qaiser Bashir, Carlos Alejandro Litovich, Hervé Finel, Yue Chen, Ariane Boumendil, Jasmine Zain, Luca Castagna, Amanda F. Cashen, Didier Blaise, Mazyar Shadman, Rocco Pastano, Farhad Khimani, Mutlu Arat, Sascha Dietrich, Norbert Schmitz, Bertram Glass, Mohamed A. Kharfan-Dabaja, Paolo Corradini, Craig S. Sauter, Silvia Montoto, Mi Kwon, Alex F. Herrera, Peter Dreger
Journal: Blood Advances
Blood Adv (2022) 6 (3): 920–930.
https://doi.org/10.1182/bloodadvances.2021005899
Published: 2022
Includes: Supplemental data
Journal Articles

An autologous culture model of nodal B-cell lymphoma identifies ex vivo determinants of response to bispecific antibodies

Tobias Roider, Berit J. Brinkmann, Vladislav Kim, Mareike Knoll, Carolin Kolb, Philipp M. Roessner, Marie Bordas, Peter Dreger, Carsten Müller-Tidow, Wolfgang Huber, Martina Seiffert, Sascha Dietrich
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5060–5071.
https://doi.org/10.1182/bloodadvances.2021005400
Published: 2021
Includes: Supplemental data
Journal Articles

Fatal late-onset CAR T-cell–mediated encephalitis after axicabtagene-ciloleucel in a patient with large B-cell lymphoma

Clinical Trials & Observations
Susanne Jung, Jochen Greiner, Stephanie von Harsdorf, Pavle Popovic, Roland Moll, Jens Schittenhelm, Kosmas Kandilaris, Volker Daniel, Alexander Kunz, Michael Schmitt, Peter Dreger
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3789–3793.
https://doi.org/10.1182/bloodadvances.2021004889
Published: 2021
Includes: Supplemental data
Journal Articles

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Clinical Trials & Observations
Nora Liebers, Johannes Duell, Donnacha Fitzgerald, Andrea Kerkhoff, Daniel Noerenberg, Eva Kaebisch, Fabian Acker, Stephan Fuhrmann, Corinna Leng, Manfred Welslau, Jens Chemnitz, Jan-Moritz Middeke, Thomas Weber, Udo Holtick, Ralf Trappe, Roald Pfannes, Ruediger Liersch, Christian Spoer, Stefan Fuxius, Niklas Gebauer, Léandra Caillé, Thomas Geer, Christian Koenecke, Ulrich Keller, Rainer Claus, Dimitrios Mougiakakos, Stephanie Mayer, Andreas Huettmann, Christiane Pott, Arne Trummer, Gerald Wulf, Uta Brunnberg, Lars Bullinger, Georg Hess, Carsten Mueller-Tidow, Bertram Glass, Georg Lenz, Peter Dreger, Sascha Dietrich
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2707–2716.
https://doi.org/10.1182/bloodadvances.2020004155
Published: 2021
Includes: Supplemental data
Journal Articles

CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma: an intent-to-treat comparison

Clinical Trials & Observations
Peter Dreger, Sascha Dietrich, Maria-Luisa Schubert, Lorenz Selberg, Andrea Bondong, Mandy Wegner, Peter Stadtherr, Christoph Kimmich, Florentina Kosely, Anita Schmitt, Petra Pavel, Nora Liebers, Thomas Luft, Ute Hegenbart, Aleksandar Radujkovic, Anthony Dick Ho, Carsten Müller-Tidow, Michael Schmitt
Journal: Blood Advances
Blood Adv (2020) 4 (24): 6157–6168.
https://doi.org/10.1182/bloodadvances.2020003036
Published: 2020
Includes: Supplemental data
Journal Articles

Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents

Lindsey E. Roeker, Peter Dreger, Jennifer R. Brown, Oscar B. Lahoud, Toby A. Eyre, Danielle M. Brander, Alan Skarbnik, Catherine C. Coombs, Haesook T. Kim, Matthew Davids, Steven T. Manchini, Gemlyn George, Nirav Shah, Timothy J. Voorhees, Kim H. Orchard, Harriet S. Walter, Arvind K. Arumainathan, Andrea Sitlinger, Jae H. Park, Mark B. Geyer, Andrew D. Zelenetz, Craig S. Sauter, Sergio A. Giralt, Miguel-Angel Perales, Anthony R. Mato
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3977–3989.
https://doi.org/10.1182/bloodadvances.2020001956
Published: 2020
Journal Articles

PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL

Clinical Trials & Observations
Peter Dreger, Anna Sureda, Kwang Woo Ahn, Mary Eapen, Carlos Litovich, Herve Finel, Ariane Boumendil, Ajay Gopal, Alex F. Herrera, Christoph Schmid, José Luis Diez-Martin, Ephraim Fuchs, Javier Bolaños-Meade, Mahasweta Gooptu, Monzr M. Al Malki, Luca Castagna, Stefan O. Ciurea, Alida Dominietto, Didier Blaise, Fabio Ciceri, Johanna Tischer, Paolo Corradini, Silvia Montoto, Stephen Robinson, Zafer Gülbas, Mehdi Hamadani
Journal: Blood Advances
Blood Adv (2019) 3 (3): 360–369.
https://doi.org/10.1182/bloodadvances.2018027748
Published: 2019
Includes: Supplemental data
Journal Articles

Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study

Clinical Trials & Observations
Salyka Sengsayadeth, Katie S. Gatwood, Ariane Boumendil, Myriam Labopin, Jürgen Finke, Arnold Ganser, Matthias Stelljes, Gerhard Ehninger, Dietrich Beelen, Dietger Niederwieser, Didier Blaise, Peter Dreger, Ghulam Mufti, Patrice Chevallier, Audrey Mailhol, Maria H. Gilleece, Norbert Gorin, Jordi Esteve, Fabio Ciceri, Frederic Baron, Christoph Schmid, Sebastian Giebel, Mohamad Mohty, Bipin N. Savani, Arnon Nagler
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2127–2135.
https://doi.org/10.1182/bloodadvances.2018019976
Published: 2018